Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice

Pharmacology Biochemistry and Behavior

Volumn 122, Issue , 2014, Pages 253-260

  Ludka, Fabiana K ^a,b   Constantino, Leandra Celso ^a   Kuminek, Gislaine ^a   Binder, Luisa Bandeira ^a   Zomkowski, Andréa D E ^a   Cunha, Maurício P ^a   Dal Cim, Tharine ^a   Rodrigues, Ana Lúcia S ^a   Tasca, Carla I ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO CONTESTADO   (Brazil)

Author keywords

Antidepressant like effect; Atorvastatin; Serotonergic system; Serotonin; Statin; Tail suspension test

Indexed keywords

ATORVASTATIN; FLUOXETINE; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PAROXETINE; SEROTONIN; SEROTONIN 2A RECEPTOR; SERTRALINE; ANTIDEPRESSANT AGENT; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DOSE RESPONSE; FRONTAL CORTEX; HIPPOCAMPUS; IMMOBILITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TAIL SUSPENSION TEST; ANIMAL; BRAIN; DEPRESSION; DRUG EFFECTS; METABOLISM; TREATMENT OUTCOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; HEPTANOIC ACIDS; MALE; MICE; PYRROLES; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 84899948033     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.04.005     Document Type: Article

References (91)

1. D. Abramowski, M. Rigo, D. Duc, D. Hoyer, and M. Staufenbiel Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera Neuropharmacology 34 1995 1635 1645
2. M. Amargós-Bosch, F. Artigas, and A. Adell Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex Eur J Pharmacol 516 2005 235 238 (Pubitemid 40922743)
3. I.M. Anderson Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability J Affect Disord 58 1 2000 19 36 [Apr] (Pubitemid 30173208)
4. F. Artigas Serotonin receptors involved in antidepressant effects Pharmacol Ther 2012 10.1016/j.pharmthera.2012.09.006
5. M. Asberg, L. Traskman, and P. Thoren 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33 1976 1193 1197
6. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function 1999
7. N. Bel, and F. Artigas Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei Synapse 15 3 1993 243 245 (Pubitemid 23339517)
8. J.M. Bessa, D. Ferreira, I. Melo, F. Marques, J.J. Cerqueira, and J.A. Palha et al. The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling Mol Psychiatry 14 8 2009 764 773
9. R.W. Binfaré, A.O. Rosa, K.R. Lobato, A.R. Santos, and A.L. Rodrigues Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission Prog Neuropsychopharmacol Biol Psychiatry 33 3 2009 530 540
10. P. Blier, and F.V. Abbott J Psychiatry Neurosci 26 2001 37
11. P. Blier, and C. De Montigny Current advances and trends in the treatment of depression Trends Pharmacol Sci 15 1994 220 226 (Pubitemid 24210726)
12. M. Boldrini, M.D. Underwood, J.J. Mann, and V. Arango Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides J Psychiatr Res 42 2008 433 442 (Pubitemid 351240919)
13. J. Bosel, F. Gandor, C. Harms, M. Synowitz, P.C. Harms Djoufack, and D. Megow et al. Neuroprotective effects of atorvastatin against glutamate induced excitotoxicity in primary cortical neurons J Neurochem 92 2005 1386 1398 (Pubitemid 40389208)
14. P.S. Brocardo, J. Budni, M.P. Kaster, A.R. Santos, and A.L. Rodrigues Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems Neuropharmacology 501 2008 464 473
15. J.C. Capra, M.P. Cunha, D.G. Machado, A.D. Zomkowski, B.G. Mendes, and A.R. Santos et al. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems Behav Pharmacol 643 2010 232 238
16. J.L. Carrasco, and C. Sandner Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview Int J Clin Pract 59 12 2005 1428 1434 (Pubitemid 43922630)
17. A.F. Carvalho, J.R. Machado, and J.L. Cavalcante Augmentation strategies for treatment-resistant depression Curr Opin Psychiatry 22 2008 07 12
18. A.A. Castro, B.P. Wiemes, F.C. Matheus, F.R. Lapa, G.G. Viola, and A.R. Santos et al. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease Brain Res 4 1513 2013 103 116 10.1016/j.brainres.2013.03.029 [Epub 2013 Mar 30]
19. I. Ceglia, S. Acconcia, C. Fracasso, M. Colovic, S. Caccia, and R.W. Invernizzi Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors Br J Pharmacol 142 3 2004 469 478 (Pubitemid 38869860)
20. P. Celada, M.V. Puig, J.M. Casanovas, G. Guillazo, and F. Artigas Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors J Neurosci 21 2001 9917 9929 (Pubitemid 34184076)
21. M.P. Cunha, D.G. Machado, L.E.B. Bettio, J.C. Capra, and A.L.S. Rodrigues Interaction of zinc with antidepressants in the tail suspension test Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1913 1920
22. M.P. Cunha, F.L. Pazini, A. Oliveira, D.G. Machado, and A.L.S. Rodrigues Evidence for the involvement of 5-HT1A receptor in the acute antidepressant-like effect of creatine in mice Brain Res Bull 2013 10.1016/j.brainresbull.2013.01. 005
23. J. De Almeida, and G. Mengod Quantitative analysis of glutamatergic and GABAergic neurons expressing 5-HT(2A) receptors in human and monkey prefrontal cortex J Neurochem 103 2007 475 486 (Pubitemid 47498018)
24. P. Di Napoli, A.A. Taccardi, M. Oliver, and R. De Caterina Statins and stroke: evidence for cholesterol-independent effects Eur Heart J 23 2002 1908 1921 (Pubitemid 35448549)
25. A.S. Elhwuegi Central monoamines and their role in major depression Prog Neuropsychopharmacol Biol Psychiatry 28 2004 435 451 (Pubitemid 38490755)
26. K. Fink, V. Schmitz, C. Boing, and M. Gothert Stimulation of serotonin release in the rat brain cortex by activation of ionotropic glutamate receptors and its modulation via alpha 2-heteroreceptors Naunyn Schmiedebergs Arch Pharmacol 352 1995 394 401
27. A.E. Freitas, J. Budni, K.R. Lobato, R.W. Binfaré, D.G. Machado, and J. Jacinto et al. Antidepressant-like effect of ethanolic extract of Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 34 2010 335 343
28. A. Ghanizadeh, and A. Hedayati Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled - clinical trial Depression and Anxiety 30 2013 1084 1088
29. V. Gigliucci, G. O'Dowd, S. Casey, D. Egan, S. Gibney, and A. Harkin Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism Psychopharmacology 2013 10.1007/s00213-013-3024-x
30. R.A. Glennon, and M. Dukat Serotonin receptors and their ligands: a lack of selective agents Pharmacol Biochem Behav 40 1991 1009 1017
31. R.A. Glennon, K. Metwally, M. Dukat, A.M. Ismaiel, J. De los Angeles, and J. Herndon et al. Ketanserin and spiperone as templates for novel serotonin 5-HT(2A) antagonists Curr Top Med Chem 2 6 2002 539 558
32. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer, L.T. Clark, and D.B. Hunninghake et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Arterioscler Thromb Vasc Biol 24 2004 149 161
33. K. Hatanaka, S. Yatsugi, and T. Yamaguchi Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex Eur J Pharmacol 395 2000 23 29 (Pubitemid 30227337)
34. C. Heeschen, C.W. Hamm, U. Laufs, S. Snapinn, M. Bohm, and H.D. White Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators: withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452 (Pubitemid 34263276)
35. J.G. Hensler Serotonergic modulation of the limbic system Neurosci Biobehav Rev 30 2006 203 214 (Pubitemid 41821809)
36. D. Hoyer Molecular pharmacolology and biology of 5-Ht1c receptors Trends Pharmacol Sci 9 1988 89 94 (Pubitemid 18072556)
37. R. Invernizzi, M. Bramante, and R. Samanin Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram Brain Res 696 1995 62 66
38. S.A. Irwin, and A. Iglewicz Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care J Palliat Med 17 2010 903 908
39. F. Jacobi, H.U. Wittchen, C. Holting, M. Hofler, H. Pfister, and N. Muller et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS) Psychol Med 34 2004 597 611 (Pubitemid 38735455)
40. M.P. Kaster, A.R. Santos, and A.L.S. Rodrigues Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test Brain Res Bull 67 2005 53 61 (Pubitemid 41225318)
41. Y. Kitaichi, T. Inoue, S. Nakagawa, S. Boku, A. Kakuta, and T. Izumi et al. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats Eur J Pharmacol 647 2010 90 96
42. P.C. Koolschijn, N.E. van Haren, G.J. Lensvelt-Mulders, H.E. Hulshoff Pol, and R.S. Kahn Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies Hum Brain Mapp 30 11 2009 3719 3735
43. D.S. Kreiss, and I. Lucki Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo1 J Pharmacol Exp Ther 274 2 1995 866 876
44. C. Kriegebaum, L. Gutknecht, A. Schmitt, K.P. Lesch, and A. Reif Serotonin now: part 1. Neurobiology and developmental genetics Fortschr Neurol Psychiatr 78 2010 319 331
45. V. Krishnan, and E.J. Nestler Linking molecules to mood: new insight into the biology of depression Am J Psychiatry 167 2010 1305 1320
46. Y. Kroeze, H. Zhou, and J.R. Homberg The genetics of selective serotonin reuptake inhibitors Pharmacol Ther 2012 10.1016/j.pharmthera
47. N. Li, B. Lee, R.J. Liu, M. Banasr, J.M. Dwyer, and M. Iwata et al. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists Science 329 2010 959 964
48. J.K. Liao, and U. Laufs Pleiotropic effects of statins Annu Rev Pharmacol Toxicol 45 2005 89 118 (Pubitemid 40261799)
49. F.K. Ludka, A.D.E. Zomkowski, M.P. Cunha, T. Dal-Cim, A.L.B. Zeni, and A.L.S. Rodrigues et al. Acute atorvastatin treatment exerts antidepressant like effect in mice via the l-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels Eur Neuropsychopharmacol 23 2013 400 412
50. D.G. Machado, M.P. Kaster, R.W. Binfaré, M. Dias, A.R. Santos, and M.G. Pizzolatti et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 31 2007 421 428 (Pubitemid 46209437)
51. D.G. Machado, L.E. Bettio, M.P. Cunha, A.R. Santos, M.G. Pizzolatti, and I.M. Brighente et al. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems Eur J Pharmacol 587 2008 163 168
52. D.G. Machado, L.E.B. Bettio, M.P. Cunha, J.C. Capra, and J.B. Dalmarco Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system Prog Neuropsychopharmacol Biol Psychiatry 33 2009 642 650
53. Q.Q. Mao, Y.F. Xian, S.P. Ip, and C.T. Che Involvement of serotonergic system in the antidepressant-like effect of piperine Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 2011 1144 1147
54. G.J. Marek, L.L. Carpenter, C.J. Mcdougle, and L.H. Price Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders Neuropsychopharmacology 28 2003 402 412
55. R. Martin-Ruiz, M.V. Puig, P. Celada, D.A. Shapiro, B.L. Roth, and G. Mengog et al. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism J Neurosci 21 2001 9856 9866 (Pubitemid 34184070)
56. C.D. Mathers, and D. Loncar Projections of global mortality and burden of disease from 2002 to 2030 PLoS Med 3 2006 442
57. M.J. Millan J Pharmacol Exp Ther 2000 295
58. M.J. Millan The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review Eur J Pharmacol 500 2004 371 384 (Pubitemid 39304021)
59. M.J. Millan Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies Therapie 1138 2005 441 460
60. S.A. Montgomery, and S. Kasper Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis Int Clin Psychopharmacol Suppl 4 1995 33 40
61. C.M. Niswender, K. Herrick-Davis, G.E. Dilley, H.Y. Meltzer, J.C. Overholser, and C.A. Stockmeier et al. RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy Neuropsychopharmacology 24 2001 478 491 (Pubitemid 32244309)
62. G. Nowak, B. Legutko, P. Skolnick, and P. Popik Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors Eur J Pharmacol 26 1998 367 370 (Pubitemid 28149993)
63. D.J. Nutt The role of dopamine and norepinephrine in depression and antidepressant treatment J Clin Psychiatry 67 2006 3 8 (Pubitemid 44078106)
64. O.F. O'Leary, A.J. Bechtholt, J.J. Crowley, T.E. Hill, M.E. Page, and I. Lucki Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test Psychopharmacology (Berl) 192 2007 357 371 (Pubitemid 46701581)
65. M.F. O'Neill, and M.W. Conway Role of 5-HT1A and 5-HT1B receptors in the mediation of behavior in the forced swim test in mice Neuropsychopharmacology 598 2001 391 398 (Pubitemid 32157555)
66. T. Ouk, C. Potey, M. Laprais, S. Gautier, R. Hanf, and R. Darteil et al. PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke Fundam Clin Pharmacol 2013 10.1111/fcp.12035 [Epub ahead of print]
67. S. Parrot, P.C. Neuzeret, and L. Denoroy A rapid and sensitive method for the analysis of brain monoamine neurotransmitters using ultra-fast liquid chromatography coupled to electrochemical detection J Chromatogr 879 2011 3871 3878
68. R.V. Parsey, M.A. Oquendo, N.R. Simpson, R.T. Ogden, R. Van Heertum, and V. Arango et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 Brain Res 954 2002 173 182 (Pubitemid 35284657)
69. H. Pessoa-Mahana, R. Araya-maturana, C. Saitz, and H. Pessoa-Mahama A synthetic overview of new molecules with 5-HT1A binding affinities Mini-Rev Med Chem 3 2003 77 93
70. T.C. Piermartiri, S. Vandresen-Filho, Herculano B. de Araújo, W.C. Martins, D. Dal'agnolo, and E. Stroeh et al. Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake Neurotox Res 16 2 2009 106 115
71. T.C. Piermartiri, C.P. Figueiredo, D. Rial, F.S. Duarte, S.C. Bezerra, and G. Mancini et al. Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage Exp Neurol 226 2 2010 274 284
72. R.A. Posada-Duque, D. Velasquez-Carvajal, G.P. Eckert, and G.P. Cardona-Gomez Atorvastatin requires geranylgeranyl transferase-I and Rac1 activation to exert neuronal protection and induce plasticity Neurochem Int 62 4 2013 433 445
73. T. Posser, M.P. Kaster, S.C. Barauna, J.B. Rocha, A.L. Rodrigues, and R.B. Leal Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system Eur J Pharmacol 602 2009 85 91
74. E. Pralong, P. Magistretti, and R. Stoop Cellular perspectives on the glutamate and monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders Prog Neurobiol 67 173 2002 202
75. J.P. Redrobe, M. Bourin, M.C. Colombel, and G.B. Baker Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity Psychopharmacology (Berl) 138 1998 1 8 (Pubitemid 28319041)
76. T.W. Robbins, and A.F. Arnsten The neuropsychopharmacology of fronto-executiv function: monoaminergic modulation Annu Rev Neurosci 32 2009 267 287
77. A.L.S. Rodrigues, G.L. da Silva, A.S. Mateussi, E.S. Fernandes, O.G. Miguel, and R.A. Yunes et al. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus 2002
78. A. Roy, J. De Jong, and M. Linnoila Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study Arch Gen Psychiatry 46 1989 609 612 (Pubitemid 19180339)
79. N. Santana, A. Bortolozzi, J. Serrats, G. Mengod, and F. Artigas Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex Cereb Cortex 14 2004 1100 1109 (Pubitemid 39258165)
80. T. Santos, M.M. Baungratz, S.P. Haskel, D.D. de Lima, J.N. da Cruz, and D.D. Magro et al. Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression Neuropsychiatr Dis Treat 8 2012 413 422
81. P. Skolnick, R.T. Layer, P. Popik, G. Nowak, I.A. Paul, and R. Trullas Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression Pharmacopsychiatry 29 1996 23 26 (Pubitemid 26072654)
82. K. Stêpieñ, M. Tomaszewski, and S.J. Czuczwar Neuroprotective properties of statins Pharmacol Rep 57 2002 561 569
83. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370 (Pubitemid 15123115)
84. C.A. Stockmeier, L.A. Shapiro, G.E. Dilley, T.N. Kolli, L. Friedman, and G. Rajkowska Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity J Neurosci 18 1998 7394 7401 (Pubitemid 28425823)
85. C.Y. Wang, P.Y. Liu, and J.K. Liao Pleiotropic effects of statin therapy: molecular mechanisms and clinical results Trends Mol Med 14 2008 37 44
86. Y.Q. Wang, Z.C. Tu, X.Y. Xu, R. Li, W.M. Qu, and Y. Urade et al. Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats J Neurochem 120 2 2012 314 324 10.1111/j1471-4159201107558x [Epub 2011 Nov 28]
87. D.W. Woolley, and E. Shaw Some neurophysiological aspects of serotonin Br Med J 4880 1954 122 126
88. Y.Q. Xu, L. Long, J.Q. Yan, L. Wei, M.Q. Pan, and H.M. Gao et al. Simvastatin induces neuroprotection in 6-OHDA-lesioned PC12 via the PI3K/AKT/caspase 3 pathway and anti-inflammatory responses CNS Neurosci Ther 19 3 2013 170 177
89. A.L.B. Zeni, A.D.E. Zomkowski, T. Dal-Cim, M. Maraschin, A.L. Rodrigues, and C.I. Tasca Antidepressant-like and neuroprotective effects of Aloysia gratissima: investigation of involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway J Ethnopharmacol 137 2011 864 874
90. A.L.B. Zeni, A.D.E. Zomkowski, M. Maraschin, A.L. Rodrigues, and C.I. Tasca Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system Eur J Pharmacol 679 2012 68 74
91. A.D.E. Zomkowski, D. Engel, N.H. Gabilan, and A.L.S. Rodrigues Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test Eur Neurophychopharmacol 20 2010 793 801